The neighborhood pharmacy—once as ubiquitous as the corner gas station—is disappearing from the American landscape at an alarming rate. CVS and Walgreens, the two dominant chains that together operate roughly 19,000 U.S. locations, are closing stores by the hundreds, creating what public health researchers term "pharmacy deserts" that now encompass 48 million Americans.

The closures represent more than corporate restructuring. For patients managing chronic conditions like diabetes, hypertension, or heart disease, distance from a pharmacy can mean skipped doses, worsened health outcomes, and emergency room visits that burden both patients and the healthcare system. The human cost of retail optimization is measured in more than lost jobs and reduced convenience.

The Closure Numbers

The scale of pharmacy retrenchment is staggering. CVS announced plans to close 270 stores in 2025 and has indicated similar numbers for 2026. Walgreens is executing a three-year plan to shutter 1,200 locations, with approximately 500 closures already completed. Rite Aid emerged from bankruptcy after closing more than 500 stores, significantly reducing the third-largest pharmacy chain's footprint.

The geographic impact is uneven. Rural communities and lower-income urban neighborhoods bear disproportionate closure burdens, as these locations generate less revenue per square foot than suburban pharmacies serving more affluent populations.

According to research compiled by pharmacy access advocates:

  • 48.4 million Americans now live in areas classified as pharmacy deserts
  • Rural residents travel an average of 15 miles to reach a pharmacy, up from 10 miles in 2020
  • Urban pharmacy deserts have expanded 23% since 2022, particularly in majority-Black and Hispanic neighborhoods
  • Medication adherence drops 40% when pharmacies are more than 10 miles away

"When a pharmacy closes, it's not just an inconvenience—it's a healthcare crisis for the community. We see patients rationing medications, skipping refills, and ending up in emergency rooms with conditions that were entirely preventable."

— Public health researcher, University of Pittsburgh

Why Pharmacies Are Failing

The economics of retail pharmacy have become punishing. Several forces are combining to make neighborhood pharmacies financially unsustainable:

Reimbursement pressure: Insurance companies and pharmacy benefit managers have steadily reduced what they pay pharmacies for dispensing prescriptions. Many pharmacies now lose money on generic medications that once provided reliable margins.

Mail-order competition: Insurers increasingly steer patients toward mail-order pharmacies that can fill prescriptions at lower cost. CVS's own Caremark unit and United Healthcare's OptumRx control substantial market share in mail-order fulfillment.

Front-of-store decline: Pharmacies historically subsidized prescription operations with profits from convenience items, cosmetics, and household goods. E-commerce has devastated these front-of-store sales as consumers order toilet paper from Amazon rather than picking it up with prescriptions.

Labor costs: Pharmacist salaries have risen as demand for the profession has grown, while pharmacy technician positions have become harder to fill at prevailing wages. Staffing a pharmacy 80+ hours per week represents substantial fixed cost that struggling locations cannot support.

Theft: Organized retail crime has made some urban pharmacy locations operationally difficult. Stores experiencing persistent theft face higher security costs and lower product availability, creating a spiral that often ends in closure.

The Health Consequences

The impact of pharmacy closures on health outcomes is documented and troubling. Patients with chronic conditions require consistent access to medications. When that access becomes difficult—requiring longer travel, arranging transportation, or navigating mail-order systems—adherence suffers.

Research published in the Journal of the American Medical Association found that patients living more than 10 miles from a pharmacy were:

40% more likely to miss medication refills
25% more likely to experience emergency hospitalizations
35% more likely to report uncontrolled chronic conditions

For conditions like diabetes and hypertension, medication adherence is literally a matter of life and death. Uncontrolled blood pressure leads to strokes and heart attacks. Unmanaged diabetes causes blindness, amputations, and kidney failure. The downstream healthcare costs of medication non-adherence dwarf any savings from pharmacy closures.

The Policy Response

Policymakers are beginning to grapple with pharmacy access as a public health issue rather than merely a market outcome. Several initiatives are emerging:

State pharmacy access laws: Some states are considering legislation requiring minimum distances between remaining pharmacies or mandating that chains maintain some presence in underserved areas.

Medicare pharmacy access requirements: Federal regulators are exploring whether Medicare Advantage plans should be required to maintain adequate pharmacy networks, preventing insurers from steering patients to mail-order options that may not serve all populations.

Telepharmacy expansion: Some states have liberalized telepharmacy rules, allowing pharmacists to supervise dispensing remotely. This enables smaller locations with pharmacy technicians to remain open without bearing full pharmacist salary costs.

Community pharmacy support: Independent pharmacies, which often serve underserved communities, are advocating for reimbursement reforms that would make their operations viable. Bills pending in Congress would require pharmacy benefit managers to pass through manufacturer rebates rather than retaining them as profit.

What Patients Can Do

For individuals navigating pharmacy closures, several strategies can help maintain medication access:

Mail-order transition: While not ideal for everyone, mail-order pharmacy can provide 90-day supplies delivered to your door. This works well for stable, long-term medications but poorly for acute prescriptions or medications requiring refrigeration.

Pharmacy consolidation: Transferring all prescriptions to a single pharmacy—even if further away—can improve efficiency and enable relationship-building with pharmacists who understand your complete medication profile.

Manufacturer programs: Many pharmaceutical companies offer patient assistance programs that can include medication delivery for those facing access challenges.

Community resources: Some communities have organized volunteer transportation services for pharmacy trips, particularly for elderly residents who no longer drive.

The disappearance of the neighborhood pharmacy represents a fundamental change in how Americans access healthcare. The convenience that previous generations took for granted is becoming a privilege of geography and income. The long-term consequences for public health are only beginning to become visible.